RSS   Newsletter   Contact   Advertise with us
Post Online Media

AGTC appoints Anne M. VanLent to its board of directors

AGTCApplied Genetic Technologies Corporation, a biotechnology company, announced it has appointed Anne M. VanLent to the company's board of directors.
Article continues below

Ms. VanLent founded and currently serves as President of AMV Advisors, an advisory firm that provides corporate strategy and financial consulting services to emerging growth life science companies.

Ms. VanLent is currently a director and chairperson of the audit committees of Aegerion Pharmaceuticals, Inc. and Ocera Therapeutics, Inc. and the lead independent director and chairperson of the audit committee of Aviragen Pharmaceuticals, Inc.

Previously, Ms. VanLent held executive roles with Barrier Therapeutics, Inc., Sarnoff Corporation and The Liposome Company, Inc.

Additionally, she has served on the boards of Onconova Therapeutics, Integra Life Sciences Holding Corporation and Penwest Pharmaceuticals.

Ms. VanLent holds a Bachelor of Arts degree in physics from Mount Holyoke College.



We use cookies to ensure that we give you the best experience on our website. Please allow cookies for fully-functioning website.

Allow Cookies Privacy Policy